XERS Xeris Biopharma Holdings, Inc.

NASDAQ
$10.46

Xeris Biopharma Holdings, Inc. (XERS) is confirmed to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $0.02 per share.

Xeris Biopharma Beat Consensus Estimates, Raises Guidance
Thursday, November 5, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs $0.02
Rev est $100.97M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.36

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Xeris Biopharma Holdings, Inc.

Xeris is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.